{
    "info": {
        "nct_id": "NCT03464136",
        "official_title": "A Phase 3b, Multicenter, Randomized, Blinded, Active-Controlled Study to Compare the Efficacy and Safety of Ustekinumab to That of Adalimumab in the Treatment of Biologic NaÃ¯ve Subjects With Moderately-to-Severely Active Crohn's Disease",
        "inclusion_criteria": "* Has Crohn's Disease (CD) or fistulizing CD of at least 3 months' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy\n* Has moderately-to-severely active CD with a baseline Crohn's disease activity index (CDAI) score of greater than or equal to (>=) 220 and less than or equal to (<=) 450\n* Has one or more ulceration on screening ileocolonoscopy (which by definition, would result in an Simple Endoscopic Score for Crohn's Disease [SES-CD] of at least 3)\n* Has failed or was intolerant to conventional therapy (corticosteroids, azathioprine [AZA], 6-mercaptopurine [6-MP] and/or methotrexate [MTX]) at adequate doses or is corticosteroid dependent\n* Has not previously received an approved biologic for Crohn's Disease (i.e., infliximab, adalimumab, certolizumab pegol, ustekinumab, natalizumab, vedolizumab or approved biosimilars of these agents)\n* Participants on oral corticosteroids (e.g., prednisone, budesonide) at a prednisone-equivalent dose of <=40 or milligram/day (mg/day) or <=9 mg/day of budesonide are budesonide <=9 mg/day are permitted if doses are stable for 3 weeks prior to baseline\n* Participants on AZA, 6-MP, or MTX at screening (or recently prior), must discontinue these medications at least 3 weeks prior to baseline\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Has complications of CD that are likely to require surgery or would confound the ability to assess the effect of ustekinumab or adalimumab treatment using the CDAI, such as: active stoma; short-gut syndrome and severe or symptomatic strictures or stenosis\n* Currently has, or is suspected to have, an abscess. Recent cutaneous and perianal abscesses are not exclusionary if drained and adequately treated at least 3 weeks prior to baseline, or 8 weeks prior for intra-abdominal abscesses, if there is no anticipated need for any further surgery. Participants with active fistulas may be included if there is no anticipation of a need for surgery and there are currently no abscesses present\n* Has had any kind of bowel resection within 6 months prior to baseline or other intra-abdominal surgery or a hospital admission for bowel obstruction within 3 months prior to baseline\n* Has a stool culture or other examination positive for an enteric pathogen, including Clostridium difficile toxin, in the last 4 months unless a repeat examination is negative and there are no signs of ongoing infection with that pathogen\n* Has received a Bacillus Calmette-Guerin (BCG) vaccination within 12 months or any other live bacterial or live viral vaccination within 2 weeks of baseline\n* Has a history of, or ongoing, chronic or recurrent infectious disease, including but not limited to, chronic renal infection, chronic chest infection, recurrent urinary tract infection (eg, recurrent pyelonephritis or chronic nonremitting cystitis), or infected skin wounds or ulcers",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has moderately-to-severely active CD with a baseline Crohn's disease activity index (CDAI) score of greater than or equal to (>=) 220 and less than or equal to (<=) 450",
            "criterions": [
                {
                    "exact_snippets": "moderately-to-severely active CD",
                    "criterion": "Crohn's disease (CD) activity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "baseline Crohn's disease activity index (CDAI) score of greater than or equal to (>=) 220 and less than or equal to (<=) 450",
                    "criterion": "Crohn's disease activity index (CDAI) score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 220,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 450,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has failed or was intolerant to conventional therapy (corticosteroids, azathioprine [AZA], 6-mercaptopurine [6-MP] and/or methotrexate [MTX]) at adequate doses or is corticosteroid dependent",
            "criterions": [
                {
                    "exact_snippets": "Has failed or was intolerant to conventional therapy (corticosteroids, azathioprine [AZA], 6-mercaptopurine [6-MP] and/or methotrexate [MTX]) at adequate doses",
                    "criterion": "conventional therapy (corticosteroids, azathioprine, 6-mercaptopurine, methotrexate)",
                    "requirements": [
                        {
                            "requirement_type": "treatment failure or intolerance",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "dose adequacy",
                            "expected_value": "adequate"
                        }
                    ]
                },
                {
                    "exact_snippets": "is corticosteroid dependent",
                    "criterion": "corticosteroid dependence",
                    "requirements": [
                        {
                            "requirement_type": "dependence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has not previously received an approved biologic for Crohn's Disease (i.e., infliximab, adalimumab, certolizumab pegol, ustekinumab, natalizumab, vedolizumab or approved biosimilars of these agents)",
            "criterions": [
                {
                    "exact_snippets": "Has not previously received an approved biologic for Crohn's Disease (i.e., infliximab, adalimumab, certolizumab pegol, ustekinumab, natalizumab, vedolizumab or approved biosimilars of these agents)",
                    "criterion": "prior biologic therapy for Crohn's Disease",
                    "requirements": [
                        {
                            "requirement_type": "history of receipt",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "drug list",
                            "expected_value": [
                                "infliximab",
                                "adalimumab",
                                "certolizumab pegol",
                                "ustekinumab",
                                "natalizumab",
                                "vedolizumab",
                                "approved biosimilars of these agents"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants on AZA, 6-MP, or MTX at screening (or recently prior), must discontinue these medications at least 3 weeks prior to baseline",
            "criterions": [
                {
                    "exact_snippets": "Participants on AZA, 6-MP, or MTX at screening (or recently prior), must discontinue these medications at least 3 weeks prior to baseline",
                    "criterion": "use of AZA, 6-MP, or MTX",
                    "requirements": [
                        {
                            "requirement_type": "discontinuation before baseline",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has one or more ulceration on screening ileocolonoscopy (which by definition, would result in an Simple Endoscopic Score for Crohn's Disease [SES-CD] of at least 3)",
            "criterions": [
                {
                    "exact_snippets": "Has one or more ulceration on screening ileocolonoscopy",
                    "criterion": "ulceration on screening ileocolonoscopy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "ulceration"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Simple Endoscopic Score for Crohn's Disease [SES-CD] of at least 3",
                    "criterion": "Simple Endoscopic Score for Crohn's Disease (SES-CD)",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has Crohn's Disease (CD) or fistulizing CD of at least 3 months' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy",
            "criterions": [
                {
                    "exact_snippets": "Has Crohn's Disease (CD) or fistulizing CD",
                    "criterion": "Crohn's Disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 3 months' duration",
                    "criterion": "Crohn's Disease duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "with colitis, ileitis, or ileocolitis",
                    "criterion": "Crohn's Disease location",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "colitis",
                                "ileitis",
                                "ileocolitis"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "confirmed at some time in the past by radiography, histology, and/or endoscopy",
                    "criterion": "Crohn's Disease confirmation",
                    "requirements": [
                        {
                            "requirement_type": "confirmation_method",
                            "expected_value": [
                                "radiography",
                                "histology",
                                "endoscopy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants on oral corticosteroids (e.g., prednisone, budesonide) at a prednisone-equivalent dose of <=40 or milligram/day (mg/day) or <=9 mg/day of budesonide are budesonide <=9 mg/day are permitted if doses are stable for 3 weeks prior to baseline",
            "criterions": [
                {
                    "exact_snippets": "Participants on oral corticosteroids (e.g., prednisone, budesonide)",
                    "criterion": "oral corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prednisone-equivalent dose of <=40 or milligram/day (mg/day)",
                    "criterion": "prednisone-equivalent dose",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 40,
                                "unit": "mg/day"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "<=9 mg/day of budesonide",
                    "criterion": "budesonide dose",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 9,
                                "unit": "mg/day"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "doses are stable for 3 weeks prior to baseline",
                    "criterion": "corticosteroid dose stability",
                    "requirements": [
                        {
                            "requirement_type": "duration of stability",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Currently has, or is suspected to have, an abscess. Recent cutaneous and perianal abscesses are not exclusionary if drained and adequately treated at least 3 weeks prior to baseline, or 8 weeks prior for intra-abdominal abscesses, if there is no anticipated need for any further surgery. Participants with active fistulas may be included if there is no anticipation of a need for surgery and there are currently no abscesses present",
            "criterions": [
                {
                    "exact_snippets": "Currently has, or is suspected to have, an abscess.",
                    "criterion": "abscess",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Recent cutaneous and perianal abscesses are not exclusionary if drained and adequately treated at least 3 weeks prior to baseline",
                    "criterion": "cutaneous and perianal abscesses",
                    "requirements": [
                        {
                            "requirement_type": "treatment_status",
                            "expected_value": "drained and adequately treated"
                        },
                        {
                            "requirement_type": "time_since_treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "8 weeks prior for intra-abdominal abscesses, if there is no anticipated need for any further surgery",
                    "criterion": "intra-abdominal abscesses",
                    "requirements": [
                        {
                            "requirement_type": "treatment_status",
                            "expected_value": "drained and adequately treated"
                        },
                        {
                            "requirement_type": "time_since_treatment",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "anticipated_need_for_surgery",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Participants with active fistulas may be included if there is no anticipation of a need for surgery and there are currently no abscesses present",
                    "criterion": "active fistulas",
                    "requirements": [
                        {
                            "requirement_type": "anticipated_need_for_surgery",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "abscess_presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has a stool culture or other examination positive for an enteric pathogen, including Clostridium difficile toxin, in the last 4 months unless a repeat examination is negative and there are no signs of ongoing infection with that pathogen",
            "criterions": [
                {
                    "exact_snippets": "stool culture or other examination positive for an enteric pathogen, including Clostridium difficile toxin, in the last 4 months",
                    "criterion": "enteric pathogen detection",
                    "requirements": [
                        {
                            "requirement_type": "test type",
                            "expected_value": [
                                "stool culture",
                                "other examination"
                            ]
                        },
                        {
                            "requirement_type": "result",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "pathogen",
                            "expected_value": [
                                "enteric pathogen",
                                "Clostridium difficile toxin"
                            ]
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unless a repeat examination is negative and there are no signs of ongoing infection with that pathogen",
                    "criterion": "repeat examination for enteric pathogen",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "no signs of ongoing infection with that pathogen",
                    "criterion": "ongoing infection with enteric pathogen",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has complications of CD that are likely to require surgery or would confound the ability to assess the effect of ustekinumab or adalimumab treatment using the CDAI, such as: active stoma; short-gut syndrome and severe or symptomatic strictures or stenosis",
            "criterions": [
                {
                    "exact_snippets": "Has complications of CD that are likely to require surgery",
                    "criterion": "complications of Crohn's disease",
                    "requirements": [
                        {
                            "requirement_type": "likelihood to require surgery",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "complications of CD that ... would confound the ability to assess the effect of ustekinumab or adalimumab treatment using the CDAI",
                    "criterion": "complications of Crohn's disease",
                    "requirements": [
                        {
                            "requirement_type": "potential to confound assessment of treatment effect using CDAI",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active stoma",
                    "criterion": "active stoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "short-gut syndrome",
                    "criterion": "short-gut syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "severe or symptomatic strictures or stenosis",
                    "criterion": "strictures or stenosis",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        },
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has had any kind of bowel resection within 6 months prior to baseline or other intra-abdominal surgery or a hospital admission for bowel obstruction within 3 months prior to baseline",
            "criterions": [
                {
                    "exact_snippets": "Has had any kind of bowel resection within 6 months prior to baseline",
                    "criterion": "bowel resection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "other intra-abdominal surgery",
                    "criterion": "intra-abdominal surgery",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hospital admission for bowel obstruction within 3 months prior to baseline",
                    "criterion": "hospital admission for bowel obstruction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has received a Bacillus Calmette-Guerin (BCG) vaccination within 12 months or any other live bacterial or live viral vaccination within 2 weeks of baseline",
            "criterions": [
                {
                    "exact_snippets": "Has received a Bacillus Calmette-Guerin (BCG) vaccination within 12 months",
                    "criterion": "Bacillus Calmette-Guerin (BCG) vaccination",
                    "requirements": [
                        {
                            "requirement_type": "time since vaccination",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "any other live bacterial or live viral vaccination within 2 weeks of baseline",
                    "criterion": "live bacterial or live viral vaccination (other than BCG)",
                    "requirements": [
                        {
                            "requirement_type": "time since vaccination",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has a history of, or ongoing, chronic or recurrent infectious disease, including but not limited to, chronic renal infection, chronic chest infection, recurrent urinary tract infection (eg, recurrent pyelonephritis or chronic nonremitting cystitis), or infected skin wounds or ulcers",
            "criterions": [
                {
                    "exact_snippets": "history of, or ongoing, chronic or recurrent infectious disease",
                    "criterion": "infectious disease",
                    "requirements": [
                        {
                            "requirement_type": "history or ongoing presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "chronicity or recurrence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic renal infection",
                    "criterion": "chronic renal infection",
                    "requirements": [
                        {
                            "requirement_type": "history or ongoing presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chronic chest infection",
                    "criterion": "chronic chest infection",
                    "requirements": [
                        {
                            "requirement_type": "history or ongoing presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recurrent urinary tract infection (eg, recurrent pyelonephritis or chronic nonremitting cystitis)",
                    "criterion": "recurrent urinary tract infection",
                    "requirements": [
                        {
                            "requirement_type": "history or ongoing presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "infected skin wounds or ulcers",
                    "criterion": "infected skin wounds or ulcers",
                    "requirements": [
                        {
                            "requirement_type": "history or ongoing presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}